These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21440753)

  • 1. The role of antibiotic prophylaxis in the new era of immunosuppression.
    Laftavi MR; Rostami R; Feng L; Said M; Kohli R; Dayton M; Pankewycz O
    Transplant Proc; 2011 Mar; 43(2):533-5. PubMed ID: 21440753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Universal perioperative antimicrobial prophylaxis is not necessary in kidney transplantation.
    Laftavi MR; Rostami R; Patel S; Kohli R; Laftavi H; Feng L; Said M; Dayton M; Pankewycz O
    Clin Transplant; 2012; 26(3):437-42. PubMed ID: 22004051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose RATG with or without basiliximab in renal transplantation: a matched-cohort observational study.
    Gentile G; Somma C; Gennarini A; Mastroluca D; Rota G; Lacanna F; Locatelli B; Remuzzi G; Ruggenenti P
    Am J Nephrol; 2015; 41(1):16-27. PubMed ID: 25612603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose thymoglobulin use in elderly renal transplant recipients is safe and effective induction therapy.
    Laftavi MR; Patel S; Soliman MR; Alnimri M; Kohli R; Said M; Pankewycz O
    Transplant Proc; 2011 Mar; 43(2):466-8. PubMed ID: 21440735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity in renal transplantation: the role of induction therapy on long-term outcomes.
    Patel S; Pankewycz O; Kohli R; Said M; Alnimri M; Feng L; Laftavi MR
    Transplant Proc; 2011 Mar; 43(2):469-71. PubMed ID: 21440736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rabbit antithymocyte globulin: a postoperative risk factor for sirolimus-treated renal transplant patients?
    Benavides C; Mahmoud KH; Knight R; Barcenas C; Kahan BD; Van Buren CT
    Transplant Proc; 2005 Mar; 37(2):822-6. PubMed ID: 15848544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a Weight-based Rabbit Anti-thymocyte Globulin Induction Dosing Regimen for Kidney Transplant Recipients.
    Pennington CA; Tischer SM; Lee E; Lee S; Sindelar J; Park JM
    Pharmacotherapy; 2015 Aug; 35(8):748-54. PubMed ID: 26234282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction treatment with rabbit antithymocyte globulin versus basiliximab in renal transplant recipients with planned early steroid withdrawal.
    Martin ST; Roberts KL; Malek SK; Tullius SG; Vadivel N; De Serres S; Grafals M; Elsanjak A; Filkins BA; Chandraker A; Gabardi S
    Pharmacotherapy; 2011 Jun; 31(6):566-73. PubMed ID: 21923440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation.
    Flaman F; Zieroth S; Rao V; Ross H; Delgado DH
    J Heart Lung Transplant; 2006 Nov; 25(11):1358-62. PubMed ID: 17097501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose rabbit antithymocyte globulin versus basiliximab induction therapy in low-risk renal transplant recipients: 8-year follow-up.
    Laftavi MR; Alnimri M; Weber-Shrikant E; Kohli R; Said M; Patel S; Pankewycz O
    Transplant Proc; 2011 Mar; 43(2):458-61. PubMed ID: 21440733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rabbit antithymocyte globulin versus basiliximab in renal transplantation.
    Brennan DC; Daller JA; Lake KD; Cibrik D; Del Castillo D;
    N Engl J Med; 2006 Nov; 355(19):1967-77. PubMed ID: 17093248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective randomized controlled trial of rabbit antithymocyte globulin compared with IL-2 receptor antagonist induction therapy in kidney transplantation.
    Pilch NA; Taber DJ; Moussa O; Thomas B; Denmark S; Meadows HB; McGillicuddy JW; Srinivas TR; Baliga PK; Chavin KD
    Ann Surg; 2014 May; 259(5):888-93. PubMed ID: 24513787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating safety and efficacy of rabbit antithymocyte globulin induction in elderly kidney transplant recipients.
    Khanmoradi K; Knorr JP; Feyssa EL; Parsikia A; Jawa P; Dinh DB; Campos S; Zaki RF; Ortiz JA
    Exp Clin Transplant; 2013 Jun; 11(3):222-8. PubMed ID: 23432665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basiliximab combined with low-dose rabbit anti-human thymocyte globulin: a possible further step toward effective and minimally toxic T cell-targeted therapy in kidney transplantation.
    Ruggenenti P; Codreanu I; Cravedi P; Perna A; Gotti E; Remuzzi G
    Clin J Am Soc Nephrol; 2006 May; 1(3):546-54. PubMed ID: 17699258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of basiliximab induction in low-immunological risk renal transplant recipients receiving tacrolimus-based immunosuppression.
    Gavela Martínez E; Avila Bernabeu AI; Sancho Calabuig A; Beltrán Catalán S; Escudero Quesada V; Pallardó Mateu LM
    Transplant Proc; 2009; 41(6):2337-8. PubMed ID: 19715913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prednisone withdrawal in pediatric kidney transplant recipients on tacrolimus-based immunosuppression: four-year data.
    Hamiwka LA; Burns A; Bell L
    Pediatr Transplant; 2006 May; 10(3):337-44. PubMed ID: 16677358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased incidence of acute rejection in adolescent kidney transplant recipients using antithymocyte induction and triple immunosuppression.
    Schwartz JJ; Ishitani MB; Weckwerth J; Morgenstern B; Milliner D; Stegall MD
    Transplantation; 2007 Sep; 84(6):715-21. PubMed ID: 17893604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppression induction with rabbit anti-thymocyte globulin with or without rituximab in 1000 liver transplant patients with long-term follow-up.
    Mangus RS; Fridell JA; Vianna RM; Kwo PY; Chen J; Tector AJ
    Liver Transpl; 2012 Jul; 18(7):786-95. PubMed ID: 22237953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymoglobulin induction and sirolimus versus tacrolimus in kidney transplant recipients receiving mycophenolate mofetil and steroids.
    Glotz D; Charpentier B; Abramovicz D; Lang P; Rostaing L; Rifle G; Vanrenterghem Y; Berthoux F; Bourbigot B; Delahousse M; Chalopin JM; Cassuto E; Lefrançois N
    Transplantation; 2010 Jun; 89(12):1511-7. PubMed ID: 20386144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction therapy by anti-thymocyte globulin (rabbit) versus basiliximab in deceased donor renal transplants and the effect on delayed graft function and outcomes.
    Foster CE; Weng RR; Piper M; Laugenou K; Ichii H; Lakey J; Malinoski D
    Transplant Proc; 2012 Jan; 44(1):164-6. PubMed ID: 22310605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.